BIOA

BioAge Labs Inc.

• Reuters·3d ago

  BioAge Labs CMO Paul D. Rubin disposes of common shares worth $0.2 million

• Reuters·03/27 11:08

  BIOAGE LABS INC <BIOA.O>: NEEDHAM INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $50

• TipRanks·03/27 10:30

  Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Nuvation Bio (NUVB) and BioAge Labs, Inc. (BIOA)

• TipRanks·03/27 10:27

  BioAge Labs initiated with a Buy at Needham

• Reuters·03/27 07:54

  U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings

• TipRanks·03/26 13:01

  Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Ionis Pharmaceuticals (IONS)

• TipRanks·03/25 11:16

  BioAge Labs: Early-Stage Promise in APJ Agonists Balanced by Execution Risk Supports Hold Rating

• Simply Wall St·03/24 23:14

  BioAge Labs (BIOA) Heavy Quarterly Loss Reinforces Bearish Community Narrative On Profitability

• TipRanks·03/24 20:25

  BioAge Labs files automatic mixed securities shelf

• Reuters·03/24 20:23

  BIOAGE LABS INC FILES FOR MIXED SHELF; SIZE NOT DISCLOSED - SEC FILING

• Reuters·03/24 20:23

  BioAge Announces Lead Program BGE-102 NLRP3 Inhibitor Candidate

• TipRanks·03/24 19:10

  Analysts Have Conflicting Sentiments on These Healthcare Companies: BioAge Labs, Inc. (BIOA) and Enliven Therapeutics (ELVN)

• TipRanks·03/24 19:00

  Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Establishment Labs Holdings (ESTA)

• TipRanks·03/24 13:29

  BioAge Highlights BGE-102 Progress and Financial Strength

• Seeking Alpha·03/24 13:13

  BioAge Labs GAAP EPS of -$2.24 beats by $0.08, revenue of $8.99M beats by $1.88M